Core Laboratories (NYSE:CLB) Stock Price Down 4% – Time to Sell?

Core Laboratories Inc. (NYSE:CLBGet Free Report) traded down 4% during mid-day trading on Friday . The stock traded as low as $19.06 and last traded at $19.06. 9,283 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 413,298 shares. The stock had previously closed at $19.86.

Analysts Set New Price Targets

A number of research firms recently weighed in on CLB. StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Citigroup dropped their target price on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a research report on Thursday, October 31st. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $17.00.

Check Out Our Latest Stock Report on Core Laboratories

Core Laboratories Stock Performance

The company’s 50-day moving average is $19.65 and its two-hundred day moving average is $19.63. The company has a quick ratio of 1.79, a current ratio of 2.48 and a debt-to-equity ratio of 0.55. The company has a market cap of $909.89 million, a P/E ratio of 29.82, a price-to-earnings-growth ratio of 1.35 and a beta of 2.35.

Core Laboratories (NYSE:CLBGet Free Report) last issued its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.04. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The company had revenue of $134.40 million during the quarter, compared to analyst estimates of $134.16 million. During the same quarter last year, the business posted $0.22 EPS. Core Laboratories’s quarterly revenue was up 7.2% compared to the same quarter last year. Equities analysts predict that Core Laboratories Inc. will post 0.8 EPS for the current year.

Core Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, November 25th. Stockholders of record on Monday, November 4th were given a dividend of $0.01 per share. The ex-dividend date was Monday, November 4th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.21%. Core Laboratories’s dividend payout ratio is presently 6.15%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Tidal Investments LLC lifted its position in shares of Core Laboratories by 1.7% during the third quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company’s stock worth $813,000 after acquiring an additional 716 shares in the last quarter. Barclays PLC lifted its holdings in Core Laboratories by 288.2% during the 3rd quarter. Barclays PLC now owns 83,570 shares of the oil and gas company’s stock worth $1,549,000 after purchasing an additional 62,042 shares in the last quarter. Geode Capital Management LLC boosted its stake in Core Laboratories by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company’s stock worth $19,521,000 after purchasing an additional 7,721 shares during the period. Disciplined Growth Investors Inc. MN grew its holdings in Core Laboratories by 26.7% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 5,653,591 shares of the oil and gas company’s stock valued at $104,761,000 after buying an additional 1,192,871 shares in the last quarter. Finally, Jane Street Group LLC increased its position in shares of Core Laboratories by 53.8% during the third quarter. Jane Street Group LLC now owns 71,989 shares of the oil and gas company’s stock valued at $1,334,000 after buying an additional 25,189 shares during the period. 97.81% of the stock is owned by institutional investors.

Core Laboratories Company Profile

(Get Free Report)

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.

Read More

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.